Flu season is on the horizon, while the coronavirus continues to spread with alarming speed. But what happens when the two germs collide?
It’s difficult to predict what this year’s flu season will look like, but Moderna, the company behind one of the nation’s three COVID-19 vaccines, is attempting to make the what-ifs a bit more predictable.
Moderna announced Thursday it is planning to create a single dose vaccine that serves as a booster against both COVID-19 and the influenza virus as part of it’s “novel respiratory vaccine program.”
